{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:04:03Z","timestamp":1778900643913,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spectra\u2122 VRE agar (Remel, Lenexa, KS) is a chromogenic agar that is FDA approved for screening patients for VRE colonization. The package insert recommends confirming isolates with identification and susceptibility testing, but confirming every culture delays time to result. Given the agar\u2019s historic high specificity for <jats:italic>E. faecium<\/jats:italic> isolates, we theorized the agar could be utilized as a stand-alone screening to minimize reagents and time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Our laboratory sought to develop a workflow to optimize the use of the medium.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We plated 3,815 rectal swabs to the Spectra VRE agar and compared results to traditional identification and susceptibility testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Dark blue or purple colonies on the agar demonstrated a sensitivity of 98% and specificity of 85% for detection of VRE <jats:italic>faecium<\/jats:italic>, but light blue colonies were significantly less specific for <jats:italic>E. faecalis<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We streamlined our workflow to accept dark blue or purple colonies as VRE <jats:italic>faecium<\/jats:italic> and plan to perform additional testing only on light blue colonies. Interestingly, higher quantity of growth increased the accuracy of the agar. In the future, growth quantity may be used to further streamline the workflow once more data is obtained.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12941-023-00552-8","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:08:40Z","timestamp":1672981720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a workflow for the detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from rectal swabs using the spectra VRE medium"],"prefix":"10.1186","volume":"22","author":[{"given":"Kendall","family":"Kling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Dirnberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Polanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Malczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Zembower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"4","key":"552_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/CMR.13.4.686","volume":"13","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13(4):686\u2013707. https:\/\/doi.org\/10.1128\/CMR.13.4.686.","journal-title":"Clin Microbiol Rev"},{"key":"552_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/IDR.S54125","volume":"8","author":"T O'Driscoll","year":"2015","unstructured":"O\u2019Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217\u201330. https:\/\/doi.org\/10.2147\/IDR.S54125.","journal-title":"Infect Drug Resist"},{"key":"552_CR3","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/IDR.S177247","volume":"11","author":"M Haque","year":"2018","unstructured":"Haque M, Sartelli M, McKimm J, Abu BM. Health care-associated infections\u2014an overview. Infect Drug Resist. 2018;11:2321\u201333. https:\/\/doi.org\/10.2147\/IDR.S177247.","journal-title":"Infect Drug Resist"},{"key":"552_CR4","unstructured":"CDC morbidity and mortality weekly report. August 6, 1993\/42(30); 597\u2013599."},{"issue":"3","key":"552_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/430909","volume":"41","author":"CA Diaz","year":"2005","unstructured":"Diaz CA, Granados SM, Zimmer KM, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible Enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327\u201333.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"552_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/ofid\/ofw246","volume":"4","author":"M Alevizakos","year":"2017","unstructured":"Alevizakos M, Gaitanidis A, Nasioudis D, Tori K, Flokas ME, Mylonakis E. Colonization with vancomycin-resistant enterococci and risk for bloodstream infection among patients with malignancy: a systematic review and meta-analysis. Open Forum Infect Dis. 2017;4(1):246.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"552_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1086\/512820","volume":"44","author":"RA Weinstein","year":"2007","unstructured":"Weinstein RA, Diekema DJ, Edmond MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis. 2007;44(8):1101\u20137. https:\/\/doi.org\/10.1086\/512820.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"552_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1086\/510624","volume":"195","author":"SS Huang","year":"2007","unstructured":"Huang SS, Rifas-Shiman SL, Pottinger JM, Herwaldt LA, Zembower TR, Noskin GA, Cosgrove SE, Perl TM, Curtis AB, Tokars JL, Diekema DJ, Jernigan JA, Hinrichsen VL, Yokoe DS, Platt R. Centers for disease control and prevention epicenters program, improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis. 2007;195(3):339\u201346.","journal-title":"J Infect Dis"},{"key":"552_CR9","unstructured":"SpectraTM VRE medium manual. Remel (Lenexa, Kansas)."},{"key":"552_CR10","unstructured":"Clinical and laboratory standards institute (CLSI). performance standards for antimicrobial susceptibility testing. 31st ed. CLSI Supplement M100. 2021."},{"issue":"2","key":"552_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/338234","volume":"34","author":"EM D'Agata","year":"2002","unstructured":"D\u2019Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. 2002;34(2):167\u201372. https:\/\/doi.org\/10.1086\/338234.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"552_CR12","doi-asserted-by":"publisher","first-page":"000214","DOI":"10.1099\/acmi.0.000214","volume":"3","author":"S Ping","year":"2021","unstructured":"Ping S, Mayorga-Reyes N, Price VJ, et al. Characterization of presumptive vancomycin-resistant enterococci recovered during infection control surveillance in Dallas, Texas, USA. Access Microbiol. 2021;3(3):000214. https:\/\/doi.org\/10.1099\/acmi.0.000214.","journal-title":"Access Microbiol"},{"key":"552_CR13","unstructured":"Cepheid GeneXpert\u00ae vanA PCR manual (Sunnyvale, California)."}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00552-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00552-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00552-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:08:53Z","timestamp":1672981733000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00552-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00552-8","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require ethics board approval as it involved using clinical specimens from patients as part of routine diagnostics. The specimens are used for routine infection control purposes and we studied an alternative method for screening for multi-drug resistant organisms. Consent was deemed not required as no patient identifying information was disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors of this paper have no competing interests nor competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}